1. Home
  2. CGON vs BLBD Comparison

CGON vs BLBD Comparison

Compare CGON & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • BLBD
  • Stock Information
  • Founded
  • CGON 2010
  • BLBD 1927
  • Country
  • CGON United States
  • BLBD United States
  • Employees
  • CGON N/A
  • BLBD N/A
  • Industry
  • CGON
  • BLBD Construction/Ag Equipment/Trucks
  • Sector
  • CGON
  • BLBD Consumer Discretionary
  • Exchange
  • CGON NYSE
  • BLBD Nasdaq
  • Market Cap
  • CGON 1.3B
  • BLBD 1.1B
  • IPO Year
  • CGON 2024
  • BLBD N/A
  • Fundamental
  • Price
  • CGON $24.13
  • BLBD $37.22
  • Analyst Decision
  • CGON Strong Buy
  • BLBD Strong Buy
  • Analyst Count
  • CGON 11
  • BLBD 7
  • Target Price
  • CGON $62.90
  • BLBD $56.79
  • AVG Volume (30 Days)
  • CGON 2.0M
  • BLBD 470.9K
  • Earning Date
  • CGON 05-16-2025
  • BLBD 05-07-2025
  • Dividend Yield
  • CGON N/A
  • BLBD N/A
  • EPS Growth
  • CGON N/A
  • BLBD 31.05
  • EPS
  • CGON N/A
  • BLBD 3.22
  • Revenue
  • CGON $1,139,000.00
  • BLBD $1,356,302,000.00
  • Revenue This Year
  • CGON N/A
  • BLBD $8.82
  • Revenue Next Year
  • CGON $16,237.24
  • BLBD $7.91
  • P/E Ratio
  • CGON N/A
  • BLBD $11.72
  • Revenue Growth
  • CGON 461.08
  • BLBD 7.57
  • 52 Week Low
  • CGON $14.80
  • BLBD $30.04
  • 52 Week High
  • CGON $40.47
  • BLBD $59.40
  • Technical
  • Relative Strength Index (RSI)
  • CGON 51.00
  • BLBD 59.09
  • Support Level
  • CGON $21.00
  • BLBD $34.19
  • Resistance Level
  • CGON $30.23
  • BLBD $39.32
  • Average True Range (ATR)
  • CGON 2.31
  • BLBD 1.42
  • MACD
  • CGON 0.16
  • BLBD 0.32
  • Stochastic Oscillator
  • CGON 34.09
  • BLBD 67.29

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

Share on Social Networks: